Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer
- 1 April 2004
- journal article
- Published by Elsevier in Kidney International
- Vol. 65 (4), 1280-1289
- https://doi.org/10.1111/j.1523-1755.2004.00536.x
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Modulation of the immune response mediated by oral transgene administration of IL-10Cellular Immunology, 2002
- Aquaporin gene delivery to kidneyKidney International, 2002
- Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failureKidney International, 2000
- Anti-Adenovirus Immune Responses in Rats Are Enhanced by Interleukin 4 but Not Interleukin 10 Produced by Recombinant AdenovirusHuman Gene Therapy, 1998
- ADENOVIRUS-MEDIATED GENE TRANSFER IN RAT LIVER OF INTERLEUKIN 4 BUT NOT INTERLEUKIN 10 PRODUCES SEVERE ACUTE HEPATITISCytokine, 1997
- Interleukin-1 in crescentic glomerulonephritisKidney International, 1995
- Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivoEuropean Journal of Immunology, 1993
- Depletion of CD8 positive cells in nephrotoxic serum nephritis of WKY ratsKidney International, 1992
- Biological properties of interleukin 10Immunology Today, 1992
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991